Definium Therapeutics Inc.
DFTX | NASDAQ
$33.38
-$2.95 (-8.12%)
Nov 2, 2026, 11:23 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 527K | 527K | 527K | 527K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | -527K | -527K | -527K | -527K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -227.54M | -193.37M | -166.31M | -151.19M | -130.32M | -113.87M | -103.92M | -93.66M | -90.48M | -95.21M | -93.87M | -85.56M | -80.93M | -68.69M | -66.33M | -69.99M | -70.23M | -98.51M | -93.85M | -109.33M | -99.58M | -60.25M |
Interest Income | 12.8M | 11.98M | 10.96M | 10.75M | 11.99M | 12.34M | 11.56M | 9.18M | 7.17M | 5.44M | 5.14M | 5.29M | 4.16M | 2.85M | 1.49M | 415K | 55K | -27K | -5K | 11.32K | 13.84K | 16.73K |
Pretax Income | -353.79M | -237.54M | -183.79M | -168.1M | -114.52M | -77.63M | -108.68M | -97.8M | -102.04M | -125.32M | -95.73M | -76.77M | -75.33M | -63.16M | -56.8M | -69.88M | -70.59M | -98.89M | -94.19M | -88.72M | -80.2M | -40.66M |
Net Income | -353.79M | -237.54M | -183.79M | -168.1M | -114.52M | -77.63M | -108.68M | -97.8M | -102.04M | -125.32M | -95.73M | -76.77M | -75.33M | -63.16M | -56.8M | -68.72M | -69.43M | -97.73M | -93.04M | -88.72M | -80.2M | -40.66M |
Selling & General & Admin | 72.9M | 57.58M | 48.64M | 45.29M | 38.2M | 36.92M | 38.62M | 38.58M | 39.38M | 43.98M | 41.74M | 36.15M | 36.95M | 30.16M | 30.16M | 31.77M | 30.76M | 60.29M | 58.76M | 59.49M | 53.43M | 19.47M |
Research & Development | 154.65M | 135.79M | 117.67M | 105.9M | 92.11M | 76.95M | 64.77M | 54.56M | 50.57M | 50.7M | 52.13M | 49.41M | 43.98M | 38.53M | 36.17M | 38.22M | 39.47M | 38.22M | 34.79M | 32.06M | 28.39M | 23.01M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 300K | 17.77M | 17.77M | 17.77M |
Operating Expenses | 227.54M | 193.37M | 166.31M | 151.19M | 130.32M | 113.87M | 103.39M | 93.13M | 89.96M | 94.68M | 93.87M | 85.56M | 80.93M | 68.69M | 66.33M | 69.99M | 70.23M | 98.51M | 93.85M | 109.33M | 99.58M | 60.25M |
Interest Expense | 13.45M | 14.55M | 13.91M | 4.87M | 4.32M | 2.45M | 2.28M | 1.63M | 1.23M | 839K | 481K | 481K | 153K | 76K | 27K | 386K | 450K | 519K | 492K | 297K | 233K | 164K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.29M | -1.73M | -415K |
Cost & Expenses | 227.54M | 193.37M | 166.31M | 151.19M | 130.32M | 113.87M | 103.92M | 93.66M | 90.48M | 95.21M | 93.87M | 85.56M | 80.93M | 68.69M | 66.33M | 69.99M | 70.23M | 98.51M | 93.85M | 109.33M | 99.58M | 60.25M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.16M | -1.16M | -1.16M | -1.16M | n/a | n/a | n/a |
Shares Outstanding (Basic) | 110.68M | 108.79M | 89.33M | 85.89M | 85.35M | 85.07M | 83.93M | 77.91M | 71.91M | 47.86M | 40.28M | 39.72M | 38.58M | 38.08M | 37.98M | 29.3M | 28.24M | 28.15M | 28.05M | 28M | 27.04M | 25.94M |
Shares Outstanding (Diluted) | 110.68M | 108.79M | 89.33M | 85.89M | 85.35M | 87.09M | 83.93M | 80.24M | 71.91M | 47.86M | 40.28M | 39.72M | 38.58M | 38.08M | 37.98M | 29.3M | 28.24M | 28.15M | 28.05M | 28.01M | 27.39M | 25.97M |
EPS (Basic) | -3.44 | -2.50 | -2.06 | -1.96 | -1.36 | -0.94 | -1.81 | -1.99 | -2.26 | -2.94 | -2.45 | -1.99 | -2.09 | -1.93 | -1.94 | -5.13 | -5.41 | -6.15 | -6.06 | -3.22 | -2.85 | -1.84 |
EPS (Diluted) | -3.43 | -2.49 | -2.13 | -2.04 | -1.43 | -1.01 | -1.80 | -1.98 | -2.26 | -2.94 | -2.45 | -1.99 | -2.09 | -1.93 | -1.94 | -5.13 | -5.41 | -6.14 | -6.05 | -3.21 | -2.84 | -1.84 |
EBITDA | -339.7M | -222.35M | -169.88M | -162.5M | -97.63M | -62.62M | -93.31M | -83.02M | -98.71M | -121.58M | -92.09M | -73.13M | -72.02M | -59.89M | -53.59M | -67.1M | -67.75M | -96.01M | -90.74M | -88.13M | -79.27M | -40.75M |
EBIT | -340.34M | -222.99M | -169.88M | -163.23M | -110.19M | -75.18M | -106.4M | -96.18M | -100.81M | -124.48M | -95.25M | -76.29M | -75.18M | -63.08M | -56.77M | -69.49M | -70.14M | -98.37M | -93.49M | -91.01M | -81.5M | -42.34M |
Depreciation & Amortization | 637.75K | 637.75K | 6.75K | 731.75K | 12.56M | 12.56M | 13.09M | 13.15M | 2.11M | 2.9M | 3.16M | 3.16M | 3.16M | 3.19M | 3.18M | 2.39M | 2.39M | 2.35M | 2.75M | 2.88M | 2.23M | 1.59M |
Add to Watchlist
Select watchlists to add or remove DFTX